Page last updated: 2024-08-23

etoposide and dihydropyridines

etoposide has been researched along with dihydropyridines in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebisu, H; Inaba, M; Mitsuhashi, J; Shinoda, H; Tsuruo, T1
Egle, A; Grunicke, H; Hofmann, J; Ueberall, F1
Kiue, A; Kohno, K; Kuwano, M; Naito, A; Okumura, M; Sano, T1
Kiue, A; Kohno, K; Kuwano, M; Takano, H; Watanabe, Y1
Kiue, A; Kuwano, M; Nakagawa, M; Nomura, Y; Ogata, J; Tanimura, H; Tasaki, Y1
Boer, R; Ferry, DR; Gekeler, V; Ise, W; Kerr, DJ; Malkhandi, J1
Hidaka, H; Minamino, T; Miyamoto, K; Nakamura, S; Nomura, M; Wakusawa, S1
Bertola, A; Boiocchi, M; Corona, G; Sorio, R; Toffoli, G1

Other Studies

8 other study(ies) available for etoposide and dihydropyridines

ArticleYear
Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dihydropyridines; Doxorubicin; Drug Resistance; Drug Synergism; Etoposide; Female; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Pyrazoles; Vincristine

1992
B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance.
    International journal of cancer, 1991, Apr-01, Volume: 47, Issue:6

    Topics: Actins; Animals; Antineoplastic Agents; Calcium Channel Blockers; Carcinoma 256, Walker; Cell Division; Cell Line; Dihydropyridines; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; HeLa Cells; Humans; KB Cells; Mammary Neoplasms, Experimental; Molecular Structure; Rats

1991
Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
    British journal of cancer, 1991, Volume: 64, Issue:2

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Male; Mice

1991
Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
    Anti-cancer drug design, 1991, Volume: 6, Issue:1

    Topics: Antineoplastic Agents; Cell Survival; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Humans; Intracellular Fluid; Neoplasms; Tritium; Tumor Cells, Cultured; Vincristine

1991
Reversal by a dihydropyridine derivative of non-P-glycoprotein-mediated multidrug resistance in etoposide-resistant human prostatic cancer cell line.
    The Journal of urology, 1995, Volume: 154, Issue:3

    Topics: Cell Line; Dihydropyridines; Drug Resistance, Multiple; Etoposide; Humans; Male; Prostatic Neoplasms; RNA, Messenger; Sulfur Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay

1995
Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
    European journal of pharmacology, 1994, Dec-15, Volume: 288, Issue:1

    Topics: Allosteric Regulation; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cell Division; Cyclosporine; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Kinetics; Mathematics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tritium; Tumor Cells, Cultured; Vinblastine; Vincristine

1994
Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
    Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:6

    Topics: Affinity Labels; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Camptothecin; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Irinotecan; Isoquinolines; Protein Binding; Protein Kinase Inhibitors; Rats; Sulfonamides; Tritium; Tumor Cells, Cultured; Vinblastine

1996
Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells.
    International journal of cancer, 1997, May-29, Volume: 71, Issue:5

    Topics: Affinity Labels; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Membrane; Chromatography, High Pressure Liquid; Cyclosporine; Dihydropyridines; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Etoposide; Humans; Hydroxylation; Kinetics; Methylation; Molecular Structure; Paclitaxel; Photochemistry; Tumor Cells, Cultured

1997